• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过评估急性期蛋白浓度监测犬肾上腺皮质功能亢进对曲洛司坦治疗的反应。

Monitoring the response of canine hyperadrenocorticism to trilostane treatment by assessment of acute phase protein concentrations.

作者信息

Arteaga A, Dhand N K, McCann T, Knottenbelt C M, Tebb A J, Evans H, Eckersall P David, Ramsey I K

机构信息

Faculty of Veterinary Medicine, University of Glasgow, Glasgow, UK.

出版信息

J Small Anim Pract. 2010 Apr;51(4):204-9. doi: 10.1111/j.1748-5827.2009.00863.x.

DOI:10.1111/j.1748-5827.2009.00863.x
PMID:20406368
Abstract

BACKGROUND

Acute phase proteins (APPS) include haptoglobin (Hp), C-reactive protein (CRP) and serum amyloid A (SAA). Increased Hp concentrations may be induced by endogenous or exogenous glucocorticoids in dogs.

OBJECTIVES

To assess whether control of hyperadrenocorticism (HAC) affects the concentrations of Hp, CRP, SAA, alkaline phosphatase (ALKP) and cholesterol, to determine whether these analytes can be used to assess control of HAC following trilostane treatment, and whether a combination of these tests offers a valid method of assessing disease control.

METHODS

Hp, CRP, SAA, ALKP and cholesterol were assessed in 11 dogs with spontaneous HAC before and after treatment with trilostane. Adequate control of HAC was defined as post-ACTH cortisol less than 150 nmol/l.

RESULTS

Significant reductions in Hp, ALKP, cholesterol and SAA (P<0.05) but not of CRP were found after control of HAC. Only Hp, cholesterol and ALKP were moderately informative (Se & Sp>0.7) of disease control when compared to adrenocorticotropin or corticotropin (ACTH) stimulation test. SAA and CRP were unhelpful (Se & Sp<0.7). The analysis of the combination of the analytes did not improve the correlation with ACTH stimulation test.

CLINICAL RELEVANCE

Relying on these analytes does not provide additional information over ACTH stimulation test results when assessing control of HAC treated with trilostane.

摘要

背景

急性期蛋白(APPs)包括触珠蛋白(Hp)、C反应蛋白(CRP)和血清淀粉样蛋白A(SAA)。犬体内内源性或外源性糖皮质激素可导致Hp浓度升高。

目的

评估控制肾上腺皮质功能亢进(HAC)是否会影响Hp、CRP、SAA、碱性磷酸酶(ALKP)和胆固醇的浓度,确定这些分析物是否可用于评估曲洛司坦治疗后HAC的控制情况,以及这些检测的组合是否提供了一种评估疾病控制的有效方法。

方法

对11只自发性HAC犬在曲洛司坦治疗前后进行Hp、CRP、SAA、ALKP和胆固醇检测。HAC的充分控制定义为促肾上腺皮质激素(ACTH)刺激后皮质醇低于150 nmol/l。

结果

控制HAC后,发现Hp、ALKP、胆固醇和SAA显著降低(P<0.05),但CRP未降低。与促肾上腺皮质激素或促肾上腺皮质素(ACTH)刺激试验相比,只有Hp、胆固醇和ALKP对疾病控制具有中等信息量(敏感性和特异性>0.7)。SAA和CRP无帮助(敏感性和特异性<0.7)。分析物组合的分析并未改善与ACTH刺激试验的相关性。

临床意义

在用曲洛司坦治疗的HAC控制评估中,依靠这些分析物并不能比ACTH刺激试验结果提供更多信息。

相似文献

1
Monitoring the response of canine hyperadrenocorticism to trilostane treatment by assessment of acute phase protein concentrations.通过评估急性期蛋白浓度监测犬肾上腺皮质功能亢进对曲洛司坦治疗的反应。
J Small Anim Pract. 2010 Apr;51(4):204-9. doi: 10.1111/j.1748-5827.2009.00863.x.
2
Haptoglobin concentrations in dogs undergoing trilostane treatment for hyperadrenocorticism.接受曲洛司坦治疗的肾上腺皮质功能亢进犬的触珠蛋白浓度。
Vet Clin Pathol. 2005 Sep;34(3):255-8. doi: 10.1111/j.1939-165x.2005.tb00050.x.
3
Evaluation of the use of baseline cortisol concentration as a monitoring tool for dogs receiving trilostane as a treatment for hyperadrenocorticism.评估将基础皮质醇浓度用作接受曲洛司坦治疗肾上腺皮质功能亢进症犬只的监测工具的情况。
J Am Vet Med Assoc. 2010 Oct 1;237(7):801-5. doi: 10.2460/javma.237.7.801.
4
Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane.用曲洛司坦治疗的垂体依赖性肾上腺皮质功能亢进犬的皮质醇、醛固酮、皮质醇前体、雄激素和内源性促肾上腺皮质激素浓度
Domest Anim Endocrinol. 2006 Jul;31(1):63-75. doi: 10.1016/j.domaniend.2005.09.004. Epub 2005 Sep 27.
5
The role of acute phase proteins in diagnosis and management of steroid-responsive meningitis arteritis in dogs.急性期蛋白在犬类固醇反应性脑膜动脉炎诊断和治疗中的作用
Vet J. 2009 Oct;182(1):125-30. doi: 10.1016/j.tvjl.2008.05.001. Epub 2008 Jun 30.
6
Trilostane in dogs.曲洛司坦在犬类中的应用。
Vet Clin North Am Small Anim Pract. 2010 Mar;40(2):269-83. doi: 10.1016/j.cvsm.2009.10.008.
7
Analytical validation of commercially available methods for acute phase proteins quantification in pigs.猪急性期蛋白定量商业可用方法的分析验证
Res Vet Sci. 2007 Aug;83(1):133-9. doi: 10.1016/j.rvsc.2006.10.005. Epub 2006 Dec 1.
8
Changes in CRP, SAA and haptoglobin produced in response to ovariohysterectomy in healthy bitches and those with pyometra.健康母犬和患有子宫蓄脓的母犬在卵巢子宫切除术后产生的CRP、SAA和触珠蛋白的变化。
Theriogenology. 2007 Jan 15;67(2):321-7. doi: 10.1016/j.theriogenology.2006.07.019. Epub 2006 Sep 8.
9
Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism.对患有自然发生的肾上腺皮质功能亢进的犬只口服给予每日两次低剂量曲洛司坦治疗的评估。
J Am Vet Med Assoc. 2008 May 1;232(9):1321-8. doi: 10.2460/javma.232.9.1321.
10
The effect of trilostane treatment on circulating thyroid hormone concentrations in dogs with pituitary-dependent hyperadrenocorticism.曲洛司坦治疗对垂体依赖性肾上腺皮质功能亢进犬循环甲状腺激素浓度的影响。
J Small Anim Pract. 2008 Mar;49(3):139-43. doi: 10.1111/j.1748-5827.2007.00509.x. Epub 2007 Dec 18.

引用本文的文献

1
Serum Bile Acids Concentrations and Liver Enzyme Activities after Low-Dose Trilostane in Dogs with Hyperadrenocorticism.低剂量曲洛司坦治疗肾上腺皮质功能亢进犬后的血清胆汁酸浓度和肝酶活性
Animals (Basel). 2023 Oct 18;13(20):3244. doi: 10.3390/ani13203244.
2
Serum Ferritin in Obese Dogs: Changes and Comparison with Other Analytes.肥胖犬的血清铁蛋白:变化及与其他分析物的比较
Vet Sci. 2023 Jul 11;10(7):457. doi: 10.3390/vetsci10070457.
3
Metabolomic Abnormalities in Serum from Untreated and Treated Dogs with Hyper- and Hypoadrenocorticism.
患有肾上腺皮质功能亢进和减退的未经治疗及已治疗犬血清中的代谢组学异常
Metabolites. 2022 Apr 9;12(4):339. doi: 10.3390/metabo12040339.
4
Comparison of methods to monitor dogs with hypercortisolism treated with trilostane.比较监测用曲洛司坦治疗的高皮质醇血症犬的方法。
J Vet Intern Med. 2021 Nov;35(6):2616-2627. doi: 10.1111/jvim.16269. Epub 2021 Oct 21.
5
Laboratory assessment of trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism.用三隆( trilostane )治疗患有垂体依赖性库欣病的犬的实验室评估。
J Vet Intern Med. 2020 Jul;34(4):1413-1422. doi: 10.1111/jvim.15830. Epub 2020 Jun 13.
6
Comparison of two prepill cortisol concentrations in dogs with hypercortisolism treated with trilostane.使用曲洛司坦治疗的高皮质醇血症犬两种服药前皮质醇浓度的比较。
BMC Vet Res. 2018 Dec 27;14(1):417. doi: 10.1186/s12917-018-1750-3.
7
Effect of Intravenous or Perivascular Injection of Synthetic Adrenocorticotropic Hormone on Stimulation Test Results in Dogs.静脉内或血管周围注射合成促肾上腺皮质激素对犬刺激试验结果的影响。
J Vet Intern Med. 2017 May;31(3):730-733. doi: 10.1111/jvim.14708. Epub 2017 Apr 13.
8
Pre-trilostane and three-hour post-trilostane cortisol to monitor trilostane therapy in dogs.曲洛司坦治疗前及曲洛司坦治疗后三小时的皮质醇水平,用于监测犬类的曲洛司坦治疗情况。
Vet Rec. 2016 Dec 10;179(23):597. doi: 10.1136/vr.103744. Epub 2016 Nov 1.
9
Comparison of adrenocorticotropic hormone stimulation test results started 2 versus 4 hours after trilostane administration in dogs with naturally occurring hyperadrenocorticism.在患有自然发生的肾上腺皮质功能亢进的犬中,比较曲洛司坦给药后2小时与4小时开始的促肾上腺皮质激素刺激试验结果。
J Vet Intern Med. 2014 Jul-Aug;28(4):1239-43. doi: 10.1111/jvim.12357. Epub 2014 May 26.